Relationship between intratumoral hemorrhage and overexpression of vascular endothelial growth factor (VEGF) in pituitary adenoma

Hiroshima Journal of Medical Sciences

Volumn 53, Issue 2, 2004, Pages 23-27

  Arita, Kazunori ^a   Kurisu, Kaoru ^a   Tominaga, Atsushi ^a   Sugiyama, Kazuhiko ^a   Eguchi, Kuniki ^a   Hama, Seiji ^a   Yoshioka, Hiroyuki ^a   Yamasaki, Fumiyuki ^a   Kanou, Yukari ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Hemorrhage; Pituitary adenoma; Vascular endothelial growth factor

Indexed keywords

ANTIBODY; CD34 ANTIBODY; HYPOPHYSIS HORMONE; MONOCLONAL ANTIBODY KI 67; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN ANTIBODY;

ADULT; AGED; ANTIBODY LABELING; ARTICLE; BLEEDING; CANCER TISSUE; CLINICAL ARTICLE; CORRELATION ANALYSIS; FEMALE; HUMAN; HUMAN TISSUE; HYPOPHYSIS ADENOMA; IMMUNOHISTOCHEMISTRY; MALE; MULTIVARIATE ANALYSIS; PROTEIN EXPRESSION; SCHOOL CHILD; TUMOR VOLUME;

ADENOMA; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; ANTIGENS, CD34; CHILD; FEMALE; HEMORRHAGE; HUMANS; KI-67 ANTIGEN; MALE; MIDDLE AGED; PITUITARY HORMONES, ANTERIOR; PITUITARY NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 4544308882     PISSN: 00182052     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Aiello, L.P., Pierce, E.A., Foley, E.D., Takagi, H., Chen, H., Riddle, L., Ferrara, N., King, G.L. and Smith, L.E. 1995. Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. Proc. Natl. Acad. Sci. USA 92: 10457-10461.
2. Banerjee, S.K., Sarkar, D.K., Weston, A.P., De, A. and Campbell, D.R. 1997. Overexpression of vascular endothelial growth factor and its receptor during the development of estrogen-induced rat pituitary tumors may mediate estrogen-initiated tumor angiogenesis. Carcinogenesis 18: 1155-1161.
3. Banerjee, S.K., Zoubine, M.N., Tran, T.M., Weston, A.P. and Campbell, D.R. 2000. Overexpression of vascular endothelial growth factor 164 and its co-receptor neuropilin-1 in estrogen-induced rat pituitary tumors and GH3 rat pituitary tumor cells. Int. J. Oncol. 16: 253-260.
4. Bonneville, J.F., Cattin, F., Gorczyca, W. and Hardy, J. 1993. Pituitary microadenomas: early enhancement with dynamic CT-implications of arterial blood supply and potential importance. Radiology 187: 857-861.
5. Cheng, S.Y., Nagane, M., Huang, H.S. and Cavenee, W.K. 1997. Intracerebral tumor-associated hemorrhage caused by Overexpression of the vascular endothelial growth factor isoforms VEGF121 and VEGF165 but not VEGF189. Proc. Natl. Acad. Sci. U S A 94: 12081-12087.
6. Criscuolo, G.R., Merrill, M.J. and Oldfield, E.H. 1988. Further characterization of malignant glioma-derived vascular permeability factor. J. Neurosurg. 69: 254-262.
7. Ferrara, N. and Henzel, W.J. 1989. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem. Biophys. Res. Comm. 161: 851-858.
8. Ferrara, N. 1996. Vascular endothelial growth factor. Eur. J. Cancer 32A: 2413-2422.
9. Houck, K.A., Ferrara, N., Winer, J., Cachianes, G., Li, B. and Leung, D.W. 1991. The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol. Endocrinol. 5: 1806-1814.
10. Jabboour, H.N., Boddy, S.C. and Lincolon, G.A. 1997. Pattern and localization of expression of vascular endothelial growth factor and its receptor flt-1 in the ovine pituitary gland: Expression is independent of hypothalamic control. Mol. Cell Endocrinol. 134: 91-100.
11. Kitadani, Y., Haruma, K., Tokutomi, T., Tanaka, S., Sumii, K., Carvalho, M., Kuwabara, M., Yoshida, K., Hirai, T., Kajiyama, G. and Tahara, E. 1998. Significance of vessel count and vascular endothelial growth factor in human esophageal carcinomas. Clin. Cancer Res. 4: 2195-2200.
12. Levy, A.P., Levy, N.S., Wegner, S. and Goldberg, M.A. 1995. Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia. J. Biol. Chem. 270: 13333-13340.
13. Lloyd, R.V., Scheithauer, B.W., Kuroki, T., Vidai, S., Kovacs, K. and Stefaneanu, L. 1999. Vascular Endothelial Growth Factor (VEGF) Expression in Human Pituitary Adenomas and Carcinomas. Endocr. Pathol. 10: 229-235.
14. Lohrer, P., Gloddek, J., Hopfner, U., Losa, M., Uhl, E., Pagotto, U., Stalla, G.K. and Renner, U. 2001. Vascular endothelial growth factor production and regulation in rodent and human pituitary tumor cells in vitro. Neuroendocrinology 74: 95-105.
15. Mise, M., Arii, S., Higashituji, H., Furutani, M., Miwano, M., Harada, T., Ishigami, S., Toda, Y., Nakayama, H., Fukumoto, M., Fujita, J. and Imamura, M. 1966. Clinical Significance of vascular endothelial growth factor and basic fibroblast growth factor gene expression in liver tumor. Hepatology 23: 455-464.
16. Mohr, G. and Hardy, J. 1982. Hemorrhage, necrosis, and apoplexy in pituitary adenomas. Surg. Neurol. 18: 181-189.
17. Neufeld, G., Cohen, T., Gengrinovitch, S. and Poltorak, Z. 1999. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J. 13: 9-22.
18. Nishikawa, R., Cheng, S.Y., Nagashima, R., Huang, H.J., Cavenee, W.K. and Matsutani, M. 1998. Expression of vascular endothelial growth factor in human brain tumors. Acta Neuropathol. (Berl) 96: 453-462.
19. Ogawa, S., Oku, A., Sawano, A., Yamaguchi, S., Yazaki, Y. and Shibuya, M. 1998. A novel type of vascular endothelial growth factor, VEGF-E (NZ-7 VEGF), preferentially utilizes KDR/Flk-1 receptor and carries a potent mitotic activity without heparin-binding domain. J. Biol. Chem. 47: 31273-31282.
20. Poltorak, Z., Cohen, T. and Neufeld, G. 2000. The VEGF splice variants: properties, receptors, and usage for the treatment of ischemic diseases. Herz 25: 126-129.
21. Ram, Z., Hadani, M., Berezin, M., Findler, G., Sahar, A. and Shacked, I. 1989. Intratumoral cyst formation in pituitary macroadenomas. Acta. Neurochir. (Wien) 100: 56-61.
22. Risau, W. 1997. Mechanisms of angiogenesis. Nature 386: 671-674.
23. Senger, D.R., Galli, S.J., Dvorak, A.M., Perruzzi, C.A., Harvey, V.S. and Dvorak, H.F. 1983. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219 (4587): 983-985.
24. Schweiki, D., Itin, A., Soffer, D. and Keshet, E. 1992. Vascular endothelial growth factor induced by hypoxia-initiated angiogenesis. Nature 359: 843-845.
25. Strugar, J.G., Criscuolo, G.R., Rothbart, D. and Harrington, W.N. 1995. Vascular endothelial growth/permeability factor expression in human glioma specimens: correlation with vasogenic brain edema and tumor-associated cysts. J. Neurosurg. 83: 682-689.
26. Takahashi, Y., Kitadani, Y., Bucana, C.D., Clearly, K. and Ellis, L.M. 1995. Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res. 55: 3964-3968.
27. Vaquero, J., Zurita, M., Oya, S., Coca, S., Morales, C. and Salas, C. 1999. Expression of vascular permeability factor in craniopharyngioma. J. Neurosurg. 91: 831-834.
28. Vaquero, J., Zurita, M., Oya, S., Coca, S. and Salas, C. 1999. Vascular permeability factor expression in cerebellar hemangioblastomas: correlation with tumor associated cysts. J. Neuro-Oncology 41: 3-7.
29. Yoshioka, H., Kama, S., Taniguchi, E., Sugiyama, K., Arita, K. and Kurisu, K. 1999. Peritumoral brain edema associated with meningioma. Cancer 85: 936-944.
30. Wakai, S., Yamakawa, K., Manaka, S. and Takakura, K. 1982. Spontaneous intracranial hemorrhage caused by brain tumors: its incidence and clinical significance. Neurosugery 10: 437-444.
31. Xuereb, G.P., Prichard, M.M.L. and Daniel, P.M. 1954. The hypophysial portal system of vessels in man. Q. J. Exp. Physiol. 39: 219-230.